Adamis pharmaceuticals schedules fourth quarter and full year 2022 financial results conference call and corporate update

San diego, march 14, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announced that it will host an investor conference call on thursday, march 16, 2023 at 2:00 p.m. pt to discuss its financial and operating results for the fourth quarter and full year 2022 as well as provide a corporate update. the company's fourth quarter and full year 2022 financial results news release is expected to be available after 1 p.m. pt on march 16, 2023, and on its website .
ADMP Ratings Summary
ADMP Quant Ranking